MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
Kenan Zhang(Capital Medical University), Tao Jiang(Harbin Medical University), Ruichao Chai(Capital Medical University), Guanzhang Li(Capital Medical University), Chunjie Jiang(Children's Hospital of Fudan University), Chunsheng Kang(Tianjin Medical University General Hospital), Fan Wu(Capital Medical University), Yuanhao Chang(Capital Medical University), Quanhua Mu(HKUST Shenzhen Research Institute), Zhaoshi Bao(Beijing Tian Tan Hospital), Zheng Zhao(China Medical University), Do‐Hyun Nam(Samsung Medical Center), Zhiliang Wang(China Animal Health and Epidemiology Center), Ying Zhang(Capital Medical University), Jing Chen(Central South University), Zheng Wang(Capital Medical University), Wei Zhang(Capital Medical University), Huimin Hu(Capital Medical University), Yuqing Liu(Sichuan Normal University), Fan Zeng(Chinese National Human Genome Center), Jiguang Wang(Hong Kong University of Science and Technology), Qiangwei Wang(Second Affiliated Hospital of Zhejiang University), Hanjie Liu(Capital Medical University), Zhiyan Sun(Capital Medical University), Lingxiang Wu(Shanghai Research Center for Acupuncture and Meridians), Qianghu Wang(Nanjing Brain Hospital), Rongjie Tao(Shandong University), Ulf D. Kahlert(University Hospital Magdeburg)
Cited by 5
Related Papers
Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus
|Infection Genetics and Evolution|2019|427
RNA-seq of 272 gliomas revealed a novel, recurrent <i>PTPRZ1-MET</i> fusion transcript in secondary glioblastomas
|Genome Research|2014|425
Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells
|Cancer Cell|2008|421
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
|Laboratory Investigation|2010|362
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
|Laboratory Investigation|2008|331